Nimotuzumab combined with chemotherapy as first-line treatment for advanced lung squamous cell carcinoma.

Thorac Cancer · 2018 · PMC6068447 · PMID 29920955

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, patients detected with positive EGFR expression via FISH showed a trend toward higher PR and longer median PFS, which indicates that EGFR GCN may be a possible predictive biomarker.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.